Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes

Thursday, May 3, 2012 1 min read

Key Takeaway: Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes

Full Press Release Details

Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes.